The priority review process in Canada—I think it's called fast-tracking in the United States, but ours is priority review—doesn't change the standards. Those standards are the same whether a drug is fast-tracked or not. What it does is it responds to a concern that was voiced by Canadians who were very ill when the HIV and AIDS crisis started. That was to find a way to provide medications to them more quickly. They voiced very clearly that they were willing to accept more risk for that. The standards are exactly the same.
